← Browse by Condition
Medical Condition

nk cell

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06835140 Phase 1
Recruiting

CD123-CD16-NK Cells Immunotherapy for AML

Enrollment
9 pts
Location
China
Sponsor
Chunji Gao
View Trial →